Edwards Lifesciences Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Wall Street indexes slip as oil prices rise, retail results awaited
- Trump threatens to bomb Oman over Iran stance
- Why this Wall Street strategist says the "trade is long gold"
- U.S. EV market shows signs of bottoming out: Bernstein
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Wall Street indexes slip as oil prices rise, retail results awaited
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Micron rises as White House presses Apple to avoid Chinese memory chips
- Trump threatens to bomb Oman over Iran stance
- H.C. Wainwright Reiterates Buy Rating on Soluna (SLNH)
Edwards Lifesciences (EW) PT Raised to $153 at RBC Capital
October 24, 2018 6:59 AM EDTRBC Capital analyst Glenn Novarro raised the price target on Edwards Lifesciences (NYSE: EW) to $153.00 (from $145.00) while maintaining an Outperform rating.
Novarro notes management commentary on 3Q call moderates our 2019 THV growth outlook.
... MoreEdwards Lifesciences (EW) Tops Q3 EPS by 5c, Offers Q4 Guidance
October 23, 2018 4:20 PM EDTEdwards Lifesciences (NYSE: EW) reported Q3 EPS of $1.07, $0.05 better than the analyst estimate of $1.02. Revenue for the quarter came in at $907 million versus the consensus estimate of $928.18 million.
GUIDANCE:
Edwards Lifesciences sees Q4 2018 EPS of $1.05-$1.20, versus the consensus of $1.21.... More
